UVIMOX CL 625 Tablets – Enhanced Protection Against Resistant Infections
UVIMOX CL 625 Tablets contain Amoxycillin Trihydrate and Potassium Clavulanic Acid, providing a powerful combination to treat resistant bacterial infections effectively.
Key Benefits of UVIMOX CL 625 Tablets: Amoxycillin Trihydrate 500mg + Potassium Clavulanic Acid 125mg Tablets
Broad-Spectrum Coverage: Effective against a wide range of Gram-positive and Gram-negative bacteria.
β-Lactamase Inhibition: Clavulanic Acid enhances Amoxicillin’s efficacy by overcoming bacterial resistance.
Reliable Treatment: Trusted for its safety and efficacy across multiple infection types.
Indications:
Respiratory Tract Infections
ENT Infections (Otitis Media, Sinusitis)
Skin and Soft Tissue Infections
Bone and Joint Infections










